These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17290036)
1. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Coleman RL; Stevens RJ; Retnakaran R; Holman RR Diabetes Care; 2007 May; 30(5):1292-3. PubMed ID: 17290036 [No Abstract] [Full Text] [Related]
2. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Groop PH; Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Taskinen MR; Viberti G Diabetes Care; 2007 Oct; 30(10):2706-7. PubMed ID: 17620444 [No Abstract] [Full Text] [Related]
3. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Gore MO; McGuire DK Diab Vasc Dis Res; 2009 Jan; 6(1):53-5. PubMed ID: 19156632 [No Abstract] [Full Text] [Related]
4. Are there differences in cardiovascular and metabolic risk profiles among men and women with Type2 diabetes? A cross-sectional analysis. Sridharan S; Gunathilake W; Fernando DJ; Idris I Diabet Med; 2010 Oct; 27(10):1212-4. PubMed ID: 20854390 [No Abstract] [Full Text] [Related]
5. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606 [TBL] [Abstract][Full Text] [Related]
6. Duration of diabetes, glucose control and cardiovascular risk. Emanuele NV Diabetologia; 2010 Jan; 53(1):214-5. PubMed ID: 19841889 [No Abstract] [Full Text] [Related]
7. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Holman RR; Coleman RL; Shine BS; Stevens RJ Diabetes Care; 2005 Jul; 28(7):1796-7. PubMed ID: 15983339 [No Abstract] [Full Text] [Related]
8. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. McCallum RW; Burgess JR; Greenaway TM Med J Aust; 2009 Jul; 191(1):47-8; author reply 48. PubMed ID: 19580543 [No Abstract] [Full Text] [Related]
9. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ; Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431 [No Abstract] [Full Text] [Related]
11. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803 [TBL] [Abstract][Full Text] [Related]
13. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus. Echouffo-Tcheugui JB; Kengne AP Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092 [TBL] [Abstract][Full Text] [Related]
14. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621 [TBL] [Abstract][Full Text] [Related]
15. Additional value of carotid artery intima-media thickness in cardiovascular risk assessment by Framingham risk-score in Type 2 diabetes: a retrospective cohort study. Ataoglu HE; Saler T; Uzunhasan I; Yenigun M; Yigit Z; Temiz LU; Saglam Z; Cetin F; Kumbasar B; Sar F J Diabetes; 2009 Sep; 1(3):188-93. PubMed ID: 20923538 [TBL] [Abstract][Full Text] [Related]
16. Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study. Turner RC; Millns H; Holman RR Diabetologia; 1997 Jul; 40 Suppl 2():S121-2. PubMed ID: 9248716 [No Abstract] [Full Text] [Related]
17. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Wannamethee SG; Shaper AG; Lennon L Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012 [TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Targher G; Bertolini L; Rodella S; Tessari R; Zenari L; Lippi G; Arcaro G Diabetes Care; 2007 Aug; 30(8):2119-21. PubMed ID: 17519430 [No Abstract] [Full Text] [Related]
19. UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes. Almeda-Valdes P; Cuevas-Ramos D; Mehta R; Gomez-Perez FJ; Aguilar-Salinas CA Curr Diabetes Rev; 2010 Jan; 6(1):1-8. PubMed ID: 20034373 [TBL] [Abstract][Full Text] [Related]
20. Prevention and management of cardiovascular disease in patients with diabetes mellitus: an evidence base. Yudkin JS; Blauth C; Drury P; Fuller J; Henley J; Lancaster T; Lankester J; Lean M; Pentecost B; Press V; Rothman D Diabet Med; 1996 Sep; 13(9 Suppl 4):S101-21. PubMed ID: 8894461 [No Abstract] [Full Text] [Related] [Next] [New Search]